mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |